Quantitative PCR reveals increased levels of tumor necrosis factor-α mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses

Journal of Interferon and Cytokine Research

Volumn 19, Issue 6, 1999, Pages 575-581

  Bertolotto, Antonio ^a,b   Malucchi, Simona ^a   Capobianco, Marco ^a   Manzardo, Elsa ^a   Guastamacchia, Giulia ^a   Milano, Eva ^a   Audano, Luisa ^a   Mutani, Roberto ^a  

^a H S Luigi   (Italy)

^b SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MATHEMATICAL MODEL; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RELAPSE; REPRODUCIBILITY; ULTRAVIOLET SPECTROPHOTOMETRY;

ADULT; BINDING, COMPETITIVE; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; RECURRENCE; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032779299     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313703     Document Type: Article

References (35)

1. BEUTLER, B. (1995). TNF, immunity and inflammatory disease: lesson of the past decade. J. Investig. Med. 43, 227-235.
2. HARTUNG, H.P., ARCHELOS, J.J., ZIELASEK, J., GOLD, R., KOLTZENBURG, M., REINERS, K.H., and TOKYA, K.V. (1995). Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 45, S22-S32.
3. CANNELLA, B., and RAINE, C.S. (1989). Cytokines up regulate la expression in organotype cultures of CNS tissue. J. Neuroimmunol. 24, 239-242.
4. MACKAY, F., LOETSCHER, H., STUBER, D., GEHR, G., and LESSLAUER, W. (1993). Tumor necrosis factor-α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177, 1277-1286.
5. SELMAJ, K.W., and RAINE, C.S. (1988). Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
6. VAN OOSTEN, B.W., BARKHOF, F., TRUYEN, L., BORINGA, J.B., BERTELSMANN, F.W., VON BLOMBERG, B.M.E., WOODY, J.N., HARTUNG H.-P., and POLMAN, C.H. (1996). Increased MRI activity and immune activation in two multiple sclerosis patients treated with monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47, 1531-1534.
7. BECK, J., RONDOT, P., CATINOT, L., FALCOFF, E., KIRCHNER, H., and WIETZERBIN, J. (1988). Increased production of interferon gamma and tumor necrosis factor alfa precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbation? Acta Neurol. Scand. 78, 318-323.
8. RUDICK, R.A., and RANSOHOFF, R.M. (1992). Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. Arch. Neurol. 49, 265-270.
9. SHARIEF, M.K., and THOMPSON, E.J. (1991). In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38, 27-33.
10. PHILIPPE, J., DEBRUYNE, J., LEROUX-ROELS, G., WILLEMS, A., and DEREUCK, J. (1996). In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis. Clin. Neurol. Neurosurg. 98, 286-290.
11. SPULER, S., YOURSY, T., SCHELLER, A., VOLTZ, R., HOLLER, R., HARTMANN, M., WICK, M., and HOHLFELD, R. (1996). Multiple sclerosis: prospective analysis of TNF-α and 55kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J. Neuroimmunol. 66, 57-64.
12. CHOFFLON, M., ROTH, S., JUILLARD, C., PAUNIER, A.M., JUILLARD, P., DEGGOOTE, P., and GRAU, G.E. (1997). Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis. Eur. Cytokine Netw. 8, 253-257.
13. VAN OOSTEN, B., BARKHOF, F., SCHOLTEN, P., VON BLOMBERG, B., ADER, H., and POLMAN, C. (1998). Increased production of tumor necrosis factor a, and not of interferon γ, preceding disease activity in patients with multiple sclerosis. Arch. Neurol. 55, 793-798.
14. FRANCIOTTA, D.M., GRIMALDI, L.M.E., MARTINO, G., PICCOLO, G., BERGAMASCHI, R., CITTERIO, A., and MELZI D'ERIL, G.V. (1989). Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 26, 787-789.
15. GALLO, P., PICCININO, M.G., KRZALIC, L., and TAVOLATO, B. (1989). Tumor necrosis factor alfa and neurological diseases. Failure in detecting TNF-α in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex and brain tumors. J. Neuroimmunol. 123, 41-44.
16. PETER, J.B., BOCTOR, F.N., and TOURTELOTTE, W.W. (1991). Serum and CSF levels of IL-2, sIL-2R, TNF-α and IL-1b in chronic progressive multiple sclerosis. Expected lack of clinical utility. Neurology 41, 121-123.
17. MAIMONE, D., GREGORY, S., ARNASON, B.C., and REDER, A.T. (1991). Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J. Neuroimmun. 32, 67-74.
18. MARTINO, G., CONSIGLIO, A., FRANCIOTTA, D.M., CORTI, A., FILIPPI, M., VANDENBROECK, K., SCIACCA, F.L., COMI, G., and GRIMALDI, L.M.E. (1997). Tumor necrosis factor a and its receptors in relapsing-remitting multiple sclerosis. J. Neurol. Sci. 152, 51-61.
19. WARZOCHA, K., BIENVENU, J., COIFFIER, B., and SALLES, G. (1995). Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Eur. Cytokine Netw. 6, 83-96.
20. NAVIKAS, V., HE, B., LINK, K., HILLERT, J., HAGLUND, M., SODERSTROM, M., FRIEDRIKSON, S., HOJEBERG, B., OLSSON, T., and LINK, H. (1996). Augmented expression of tumor necrosis factor-α and lymphotoxin mRNA in mononuclear cells in multiple sclerosis and optic neuritis. Brain 119, 213-223.
21. RIECKMANN, P., ALBRECHT, M., KITZE, B., WEBER, T., TUMANI, H., BROOCKS, A., LÜER, W., and POSER, S. (1994). Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523-1526.
22. RIECKMANN, P., ALBRECHT, M., KITZE, B., WEBER, T., TUMANI, H., BROOCKS, A., LÜER, W., HELWIG, A., and POSER, S. (1995). Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37, 82-88.
23. POSER, C.M., PATY, D.W., SCHEINBERG, L., McDONALD, I., DAVIS, F.A., EBERS, G.C., JOHNSON, K.P., SIBLEY, W.A., SILBERBERG, D.H., and TOURTELLOTTE, W.W. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227-231.
24. LUBLIN, F.D., and REINGOLD, S.C. (1996). Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46, 907-911.
25. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate- pheno- chloroform extraction. Anal. Biochem. 162, 156-159.
26. NEDWIN, G.E., NAYLOR, S.L., SAKAGUCHI, A.Y., SMITH, D., JARRET-NEDWIN, J., PENNICA, D., GOEDDEL, D.V., and GRAY, P.W. (1985). Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13, 6361-6373.
27. CELI, F.S., ZENILMAN, M.E., and SHULDINER, R.A. (1993). A rapid and versatile method to synthesize internal standard for competitive PCR. Nucleic Acids Res. 21, 1047.
28. RAEYMAEKERS, L. (1993). Quantitative PCR theoretical considerations with practical implications. Anal. Biochem. 214, 582-585.
29. DIVIACCO, S., NORIO, P., ZENTILIN, L., MENZO, S., CLEMENTI, M., BIOMONTI, G., RIVA, S., FALASCHI, A., and GIACCA, M. (1992). A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 122, 313-320.
30. CONNOLLY, A.R., CLELAND, L.G., and KIRKHAM, B.W. (1995). Mathematical considerations of competitive polymerase chain reaction. J. Immunol. Methods. 187, 201-211.
31. KURTZKE, J.F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
32. GILLILAND, G., PERRIN, S., BLANCHARD, K., and BUNN, H.F. (1990). Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87, 2725-2729.
33. BOUABOULA, M., LEGOUX, P., PESSÉGUÉ, B., DELPECH, B., DUMONT, X., PIECHACZYK, M., CASELLAS, P., and SHIRE, D. (1992). Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J. Biol. Chem. 267, 21830-21838.
34. LAGOON-DEENADAYALAN, S., LAGOO, A.S., BARBER, H., and HARDY, K.J. (1993). A standardized approach to PCR-based semi quantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res. 12, 59-67.
35. MCDONALD, W.I., MILLER, D.H., and BARNES, D. (1992). The pathological evolution of multiple sclerosis. Neuropathol. Appl. Neurobiol. 18, 319-334.